Physician profile
Harry D Weinstein
NPI 1568540870
$2,843.86
in general payments reported to CMS, 2019-2025
10 companies · $276 in 2025
The $276 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $744 · 2020: $30.22 · 2021: $133 · 2022: $597 · 2023: $389 · 2024: $675 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,339.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,361.77 | 2019-2025 | Total30, Precision 1, Precision7 |
| Coopervision INC. | $576.78 | 2019-2025 | Clariti Contact Lens, Myday Contact Lens |
| Bausch & Lomb Americas INC. | $205.09 | 2023-2024 | Infuse, Xiidra, Miebo |
| Johnson & Johnson Vision Care, INC. | $141.88 | 2019-2024 | Acuvue |
| Tarsus Pharmaceuticals, INC. | $114.75 | 2024 | Xdemvy |
| Shire North American Group INC | $109.72 | 2019 | |
| Dompe US, INC. | $95.62 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $88.29 | 2019 | |
| Horizon Therapeutics Plc | $83.00 | 2022 | |
| Abb Con-Cise Optical Group LLC | $66.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harry Weinstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.